The short version of investigational status fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-11 and is reviewed periodically as new material appears.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
该分子是经过结构修饰的合成肽，通过脂肪酸侧链与白蛋白结合，从而延长循环时间。皮下给药后，药物逐步释放并分布至组织。降解主要依赖蛋白酶，肾脏清除占次要地位。人体半衰期以天为单位，但准确数值随检测方法和个体差异而变；组织分布与受体占有率仍是开放问题。
临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂，并记录不良事件。药代动力学评估关注浓度-时间曲线，药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成，具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。
瑞他鲁肽同时激活GLP-1受体、GIP受体和胰高血糖素受体，这三者均属于B类G蛋白偶联受体。受体激活后主要经cAMP信号通路传递效应。GLP-1成分与食欲抑制和胃排空延缓相关，GIP成分影响脂肪组织与胰岛素分泌，胰高血糖素成分则促进肝糖输出和能量消耗。各受体贡献的相对比例在人体中尚未完全量化。
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
If {H3O+} increases {CH3CO2H} must increase and CH3CO−2 must decrease. The H2O is left out, as it is the solvent and its concentration remains high and nearly constant. J. W. Gibbs suggested in 1873 that equilibrium is attained when the "available energy" (now known as Gibbs free energy or Gibbs energy) of the system is at its minimum value, assuming the reaction is carried out at a constant temperature and pressure. What this means is that the derivative of the Gibbs energy with respect to reaction coordinate (a measure of the extent of reaction that has occurred, ranging from zero for all reactants to a maximum for all products) vanishes (because dG = 0), signaling a stationary point. This derivative is called the reaction Gibbs energy (or energy change) and corresponds to the difference between the chemical potentials of reactants and products at the composition of the reaction mixture. This criterion is both necessary and sufficient. If a mixture is not at equilibrium, the liberation of the excess Gibbs energy (or Helmholtz energy at constant volume reactions) is the "driving force" for the composition of the mixture to change until equilibrium is reached. The equilibrium constant can be related to the standard Gibbs free energy change for the reaction by the equation
==== Puberty ==== Leptin along with kisspeptin controls the onset of puberty. High levels of leptin, as usually observed in obese females, can trigger neuroendocrine cascade resulting in early menarche. This may eventually lead to shorter stature as oestrogen secretion starts during menarche and causes early closure of epiphyses.
Futures studies is the study of social and technological progress. It aims to explore the range of plausible futures and incorporate human values in the development of new technologies. More generally, futures researchers are interested in improving "the freedom and welfare of humankind". It relies on a thorough quantitative and qualitative analysis of past and present technological trends, and attempts to rigorously extrapolate them into the future. Science fiction is often used as a source of ideas. Futures research methodologies include survey research, modeling, statistical analysis, and computer simulations.
Sources: en.wikipedia.org
== Monazite zonation == Zonation is a characteristic of monazite. A single monazite grain can contain domains of distinctively different compositions and ages. These domains are widely accepted to represent episodes in geological history with monazite growth or recrystallisation. The key to monazite geochronology is to find out what geological events or environments a domain represents, by comparing its chemical composition with mineral stability and reactions. The age of the event is thus represented by the domain age. The ideal formula of monazite is [LREE(PO4)], the variation in composition is mainly due to the chemical substitutions of light rare earth elements (REE) in monazite by other elements. One of the common substitutions are the exchange between LREE with Th and Ca, and P with Si to form huttonite [Th(SiO4)] and brabantite [CaTh(PO4)2]. Since all three minerals share the same chemical structure, they are the three endmembers in their solid solution, meaning that they appear in a same solid phase where substitutions happen. The compositional zonation patterns may not be the same when we are considering different elements, and age zonation may have no relationship with compositional zonation at all. (see images from the section: analysis procedures) Thus, one needs to be very careful in linking among zonations. In natural monazite, the zonation pattern maybe complex and hard to interpret. Below we describe some simple chemical zonation patterns and the associated interpretations. Zonation patterns associated with igneous activity are usually easy to interpret.
The Cold War was a period of international geopolitical rivalry between the United States (US) and the Soviet Union (USSR) and their respective allies, the capitalist Western Bloc and communist Eastern Bloc. It began in the aftermath of the Second World War and ended with the dissolution of the Soviet Union in 1991. The term cold war is used because there was no direct fighting between the two superpowers, though each supported opposing sides in regional conflicts known as proxy wars. In addition to the struggle for ideological and economic influence and an arms race in both conventional and nuclear weapons, the Cold War was expressed through technological rivalries such as the Space Race, espionage, propaganda campaigns, embargoes, and sports diplomacy. After the end of the Second World War in 1945, during which the US and USSR had been allies, the USSR installed satellite governments in its occupied territories in Eastern Europe and North Korea by 1949, resulting in the political division of Europe (and Germany) by an "Iron Curtain". The USSR tested its first nuclear weapon in 1949, four years after the US used its own on Hiroshima and Nagasaki, and allied with the People's Republic of China, founded in 1949. The US declared the Truman Doctrine of "containment" of communism in 1947, launched the Marshall Plan in 1948 to assist Western Europe's economic recovery, and founded the NATO military alliance in 1949 (matched by the Soviet-led Warsaw Pact in 1955).
=== False correspondence with vaporization === Vaporization (from liquid to gas) is divided into two types: vaporization on the surface of the liquid is called evaporation, and vaporization at the boiling point with formation of bubbles in the interior of the liquid is called boiling. However there is no such distinction for the solid-to-gas transition, which is always called sublimation in both corresponding cases.
=== United Kingdom === In 2008, a herd of Wagyu cattle was imported to North Yorkshire, first becoming available for consumption in 2011. Since 2011, there have been Wagyu herds in Scotland. There are British & Irish Wagyu Fullbloods registered through the British Wagyu Breeders Association.
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.